
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/AB-FUBINACA: Difference between revisions
Jump to navigation
Jump to search
>BronzeManul m Fixed dose consistency. Lowered Strong min to 3mg. |
>Isaak Common names correctly annotated. |
||
(41 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
{{SubstanceBox | {{SubstanceBox | ||
<!-- | <!-- Special Parameters --> | ||
|displayClasses={{{displayClasses|}}} | |||
|MaterialTable_MaxWidth=250px | |MaterialTable_MaxWidth=250px | ||
|MaterialTable_Title={{PAGENAME}} | |MaterialTable_Title={{PAGENAME}} | ||
Line 10: | Line 11: | ||
|ModuleStructure=true | |ModuleStructure=true | ||
|ModuleNomenclature=true | |ModuleNomenclature=true | ||
|ModuleClassMembership=true | |||
|ModuleROA=true | |ModuleROA=true | ||
Line 31: | Line 33: | ||
<!-- Structure --> | <!-- Structure --> | ||
|MolecularStructureCaption= | |MolecularStructureCaption=Molecular structure of AB-FUBINACA | ||
|SkeletalImageFile=File: | |SkeletalImageFile=File:AB-FUBINACA.svg | ||
|SkeletalImageWidth= | |SkeletalImageWidth=245px | ||
|3DImageFile= | |3DImageFile= | ||
|3DImageWidth= | |3DImageWidth= | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon=Ab-fubi | |NameCommon=[[common name::Ab-fubi]] | ||
|NameSubstitution=AB-FUBINACA | |NameSubstitution=AB-FUBINACA | ||
|NameSystematic=N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide | |NameSystematic=N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide | ||
<!-- Class Membership --> | <!-- Class Membership --> | ||
|EffectClass=[[ | |EffectClass=[[Psychoactive class::Cannabinoid]] | ||
|ChemicalClass=[[ | |ChemicalClass=[[chemical class::Indazolecarboxamide]] | ||
<!-- Dosage/Duration --> | <!-- Dosage/Duration --> | ||
Line 50: | Line 52: | ||
|SmokedROA=true | |SmokedROA=true | ||
|SmokedROA_Collapsed=false | |SmokedROA_Collapsed=false | ||
|SmokedROA_Caption= | |SmokedROA_Caption= | ||
|SmokedROA_Bioavailability= | |SmokedROA_Bioavailability= | ||
|SmokedROA_Threshold=< 1 mg | |SmokedROA_Threshold=< [[Smoked threshold dose::1]] [[Smoked dose units::mg]] | ||
|SmokedROA_Light=[[Smoked min light dose::1]] - [[Smoked max light dose::2]] mg | |SmokedROA_Light=[[Smoked min light dose::1]] - [[Smoked max light dose::2]] mg | ||
|SmokedROA_Common=[[Smoked min common dose::2]] - [[Smoked max common dose::3]] mg | |SmokedROA_Common=[[Smoked min common dose::2]] - [[Smoked max common dose::3]] mg | ||
|SmokedROA_Strong=[[Smoked min strong dose::3]] - [[Smoked max strong dose::5]] mg | |SmokedROA_Strong=[[Smoked min strong dose::3]] - [[Smoked max strong dose::5]] mg | ||
|SmokedROA_Heavy= | |SmokedROA_Heavy=[[Smoked heavy dose::5]] mg + | ||
|SmokedROA_TimelineFile= | |SmokedROA_TimelineFile= | ||
|SmokedROA_TimelineWidth= | |SmokedROA_TimelineWidth= | ||
Line 63: | Line 65: | ||
|SmokedROA_Peak=[[Smoked min peak time::30]] - [[Smoked max peak time::60]] [[Smoked peak time units::minutes]] | |SmokedROA_Peak=[[Smoked min peak time::30]] - [[Smoked max peak time::60]] [[Smoked peak time units::minutes]] | ||
|SmokedROA_Offset=[[Smoked min offset time::10]] - [[Smoked max offset time::20]] [[Smoked offset time units::minutes]] | |SmokedROA_Offset=[[Smoked min offset time::10]] - [[Smoked max offset time::20]] [[Smoked offset time units::minutes]] | ||
|SmokedROA_Aftereffects=15 - 30 minutes | |SmokedROA_Aftereffects=[[Smoked min afterglow time::15]] - [[Smoked max afterglow time::30]] [[Smoked afterglow time units::minutes]] | ||
|OralROA=false | |OralROA=false | ||
|OralROA_Collapsed=true | |OralROA_Collapsed=true | ||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold=< x mg | |OralROA_Threshold=< x mg |
Latest revision as of 23:55, 12 May 2022
SubstanceBox/AB-FUBINACA | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||||||||||||||||||
Common names | Ab-fubi | ||||||||||||||||||||||||||||||
Substitutive name | AB-FUBINACA | ||||||||||||||||||||||||||||||
Systematic name | N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide | ||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||
Psychoactive class | Cannabinoid | ||||||||||||||||||||||||||||||
Chemical class | Indazolecarboxamide | ||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||
|